Fatigue and cancer: causes, prevalence and treatment approaches

Fatigue is the most prevalent cancer-related symptom and has a significant adverse impact on patients' functional ability and quality of life. Hypotheses regarding the aetiology of cancer-related fatigue are discussed, and clinical practice guidelines for the evaluation and management of oncolo...

Descripción completa

Detalles Bibliográficos
Autores principales: Wagner, L I, Cella, D
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2004
Materias:
Minireview
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409868/
https://www.ncbi.nlm.nih.gov/pubmed/15238987
http://dx.doi.org/10.1038/sj.bjc.6602012
_version_ 1782155885408157696
author Wagner, L I
Cella, D
author_facet Wagner, L I
Cella, D
author_sort Wagner, L I
collection PubMed
description Fatigue is the most prevalent cancer-related symptom and has a significant adverse impact on patients' functional ability and quality of life. Hypotheses regarding the aetiology of cancer-related fatigue are discussed, and clinical practice guidelines for the evaluation and management of oncology patients with fatigue are reviewed. Both nonpharmacologic and pharmacologic strategies for the management of fatigue are summarised.
format Text
id pubmed-2409868
institution National Center for Biotechnology Information
language English
publishDate 2004
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-24098682009-09-10 Fatigue and cancer: causes, prevalence and treatment approaches Wagner, L I Cella, D Br J Cancer Minireview Fatigue is the most prevalent cancer-related symptom and has a significant adverse impact on patients' functional ability and quality of life. Hypotheses regarding the aetiology of cancer-related fatigue are discussed, and clinical practice guidelines for the evaluation and management of oncology patients with fatigue are reviewed. Both nonpharmacologic and pharmacologic strategies for the management of fatigue are summarised. Nature Publishing Group 2004-08-31 2004-07-06 /pmc/articles/PMC2409868/ /pubmed/15238987 http://dx.doi.org/10.1038/sj.bjc.6602012 Text en Copyright © 2004 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Minireview
Wagner, L I
Cella, D
Fatigue and cancer: causes, prevalence and treatment approaches
title Fatigue and cancer: causes, prevalence and treatment approaches
title_full Fatigue and cancer: causes, prevalence and treatment approaches
title_fullStr Fatigue and cancer: causes, prevalence and treatment approaches
title_full_unstemmed Fatigue and cancer: causes, prevalence and treatment approaches
title_short Fatigue and cancer: causes, prevalence and treatment approaches
title_sort fatigue and cancer: causes, prevalence and treatment approaches
topic Minireview
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409868/
https://www.ncbi.nlm.nih.gov/pubmed/15238987
http://dx.doi.org/10.1038/sj.bjc.6602012
work_keys_str_mv AT wagnerli fatigueandcancercausesprevalenceandtreatmentapproaches
AT cellad fatigueandcancercausesprevalenceandtreatmentapproaches

Ejemplares similares